Literature DB >> 23732815

MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin.

Dong Xu1, Qingguang Wang, Yong An, Lijian Xu.   

Abstract

MicroRNAs have emerged as crucial regulators of tumorigenesis. However, the mechanism by which miR‑203 is involved in the pathogenesis of pancreatic cancer (PC) remains elusive. In the present study, PC cell lines were used as an experimental model to investigate the expression and functional role of miR‑203 in PC. miR‑203 mimic virus, miRNA negative control virus and Survivin shRNA virus were transfected into the PC cell line, CFPAC‑1. mRNA and protein levels of Survivin were detected using qPCR and western blot analysis. Proliferation, apoptosis and cell cycle profiles were detected by an MTT assay and flow cytometry. Female BALB/cA‑nu nude mice were used to validate the role of miR‑203 in vivo. The protein levels of Survivin were found to negatively correlate with miR‑203 levels in four PC cell lines. A luciferase assay revealed that Survivin was a direct target of miR‑203. Transfection with miR‑203 mimic inhibited CFPAC‑1 cell proliferation and induced apoptosis and G1 phase cell cycle arrest, similar to knockdown of Survivin. In the in vivo nude mouse model, the downregulation of Survivin by knockdown of Survivin or transfection with miR‑203 mimic inhibited tumor growth. Results of the current study indicate that miR‑203 regulates the proliferation, apoptosis and cell cycle progression of PC cells by targeting Survivin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732815     DOI: 10.3892/mmr.2013.1504

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  22 in total

Review 1.  Noncoding RNAs and pancreatic cancer.

Authors:  Juan-Fei Peng; Yan-Yan Zhuang; Feng-Ting Huang; Shi-Neng Zhang
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 2.  MicroRNAs in pancreatic malignancy: progress and promises.

Authors:  Sanjeev K Srivastava; Sumit Arora; Seema Singh; Arun Bhardwaj; Courey Averett; Ajay P Singh
Journal:  Cancer Lett       Date:  2014-02-20       Impact factor: 8.679

Review 3.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

Review 4.  MicroRNA regulation and therapeutic targeting of survivin in cancer.

Authors:  Jingcao Huang; Hui Lyu; Jianxiang Wang; Bolin Liu
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 5.  MicroRNA aberrations: An emerging field for gallbladder cancer management.

Authors:  Vishal Chandra; Jong Joo Kim; Balraj Mittal; Rajani Rai
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

6.  Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  microRNA-mediated survivin control of pluripotency.

Authors:  Kristina Kapinas; Heesun Kim; Matthew Mandeville; Lori A Martin-Buley; Carlo M Croce; Jane B Lian; Andre J van Wijnen; Janet L Stein; Dario C Altieri; Gary S Stein
Journal:  J Cell Physiol       Date:  2015-01       Impact factor: 6.384

Review 8.  MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis.

Authors:  Tereza Halkova; Romana Cuperkova; Marek Minarik; Lucie Benesova
Journal:  Gastroenterol Res Pract       Date:  2015-04-19       Impact factor: 2.260

Review 9.  Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance.

Authors:  Sanjeev K Srivastava; Sumit Arora; Courey Averett; Seema Singh; Ajay P Singh
Journal:  Biomed Res Int       Date:  2015-03-17       Impact factor: 3.411

10.  DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster.

Authors:  Sladjana Zagorac; Sonia Alcala; Gustavo Fernandez Bayon; Tony Bou Kheir; Matthieu Schoenhals; Anna González-Neira; Mario Fernandez Fraga; Alexandra Aicher; Christopher Heeschen; Bruno Sainz
Journal:  Cancer Res       Date:  2016-06-03       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.